ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Stand Up To Cancer Launches Immunology “Dream Team”

December 14, 2012

DCT Concepts Approved

October 11, 1985

In Brief: Michael Grever Named DCT Deputy Director; MSK’s Burton Lee New White House Physician

March 31, 1989

CTEP Starts New Effort to Bring Minorities Into Clinical Trials

March 2, 1990

NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy

June 24, 2011

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000